Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

Momelotinib in VEXAS syndrome Recruiting

2024-519779-24-00 VEXAS (VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, 2025-11-25
Safety and Efficacy of Tarperprumig in Adult Participants with ANCA-Associated Vasculitis Recruiting

2025-521706-17-00 Anti-neutrophil cytoplasmic antibody (ANCA)-associated 2025-11-25
A clinical study of MK-1084 in people with advanced solid tumors (MK 1084-014) Recruiting

2025-521737-91-00 Neoplasm malignant with KRAS G12C mutation 2025-11-25
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting

2025-521920-31-00 Graves’ Disease 2025-11-21
RLY-2608-201-Ph2 Study of RLY-2608 in PROS and PIK3CA Driven Malformations Recruiting

2024-518895-30-00 PIK3CA Related Overgrowth Spectrum and Malformations Dr 2025-11-21
Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) Recruiting

2024-519261-21-00 Desmoplastic small round cell tumor 2025-11-21
Foetal neural stem cells transplantation in progressive multiple sclerosis Recruiting

2024-511028-15-00 Progressive Multiple Sclerosis 2025-11-20
A study to test whether BI 1815368 helps people with an eye condition called diabetic macular edema Recruiting

2024-520384-14-00 Centre-involved diabetic macular edema 2025-11-20
A Phase 2 Study of CRD-4730 in CPVT Recruiting

2024-515564-32-00 Catecholaminergic Polymorphic Ventricular Tachycardia 2025-11-20
A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without stan… Recruiting

2025-520658-12-00 Idiopathic Pulmonary Fibrosis (IPF) 2025-11-20
A study to assess the efficacy and safety of ITI-1284 as adjunctive treatment in patients with Generalized Anxiety Disorder Recruiting

2024-513302-56-00 Generalized Anxiety Disorder 2025-11-17
A randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best in… Recruiting

2024-517018-14-00 Advanced non-small cell lung cancer 2025-11-17
TACTIC : MP0317, A TUMOR TARGETING FAP DEPENDENT CD40 AGONIST DARPIN, IN COMBINATION WITH CHEMOIMMUNOTHERAPY IN FIRST LINE TREATMENT FOR PAT… Recruiting

2024-520029-35-01 ADVANCED BILIARY TRACT CARCINOMA 2025-11-17
Impact of Glucagon on Physical Capacity and Metabolism Recruiting

2025-521835-35-00 Heart Failure with preserved Ejection Fraction (HFpEF) 2025-11-14
A Phase II, Open-Label, Single-Center, Single-Arm Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Blinatumomab for Treatmen… Recruiting

2025-523061-22-00 Granulomatous Polyangiitis 2025-11-14
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 febrile Urinary Tract Infection (fUTI) 2025-11-13
Antimalarial prophylactic efficacy of a weekly dose atovaquone-proguanil Recruiting

2024-518884-36-00 Malaria 2025-11-12
Prostate Androgen Response Investigation using a Stratification BIOmarker - PARIS-BIO Recruiting

2025-520639-17-00 High-risk localized or locally advanced prostate adenoc 2025-11-12
Digitoxin Pancreatic cancer trial-1 Recruiting

2024-512128-12-01 Pancreatic cancer 2025-11-11
IFCT-2401 SPORADIC a multicenter randomized open label phase II study evaluating the efficacy and the tolerance of adding cemiplimab to Sequ… Recruiting

2024-517316-29-00 Unresectable stage III Non-Small Cell Lung Cancer 2025-11-07
Cangrelor in endovascular stroke treatment with emergent carotid artery stenting (CANCAS) Recruiting

2025-521564-35-00 ischemic stroke with intracranial large artery occlusio 2025-11-06
A clinical study of tulisokibart in people with rheumatoid arthritis (MK-7240-014) Recruiting

2025-521745-25-00 Rheumatoid Arthritis 2025-11-06
REDI-CaP (Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients). Innovative Management of Patients with Unfavorable Intermed… Recruiting

2025-521170-33-00 Prostate Cancer 2025-11-05
Dose determination study of a mix of Dermatophagoides allergenic extracts (pteronyssinus and farinae) for immunotherapy treatment, administe… Recruiting

2025-521522-15-00 Allergic rhinitis/rhinoconjunctivitis caused by dust mi 2025-11-05